(Image credit: michaeljfox.org) When the Michael J. Fox Foundation for Parkinson’s Research launched a major study in 2010, the objective was to help scientists better understand the disease and identify markers that could improve the process of diagnosis and subsequent treatment. Sixteen years later, the initiative has grown into a global research resource. With its data downloaded over 50 million times, it has transformed the nature of Parkinson’s research and drug development.The study, originally known as the Parkinson’s Progression Markers Initiative (PPMI), reached this milestone as researchers began exploring new ways to understand the biological differences between people living with Parkinson’s disease. In May 2026, the foundation announced that the initiative would be renamed the Parkinson’s Precision Medicine Initiative, reflecting the progress made since its launch and a growing focus on treatments tailored to individual patients.The research that grew into a global resourceFor Michael J. Fox, who has publicly shared his experience of living with Parkinson’s disease since disclosing his diagnosis in 1998, the foundation's work has remained focused on advancing research ...










English (US) ·